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Coronary artery reocclusion after tbrombotysis with human 
recombina”t tirs”e-type ptesminogen actirator @t-PA) 15 retate 
to the she,, halt-life ,I ,bis age”, t” ptanna. KW, B m”(s”t of 
It-PA lacking the fibranectin fingerlike, epidermal growth factor- 
like and first kringle domains (amino acids 6 to 173) and having 
the glyrosylstion site Am’” muta@niwJ lo Gin, has been pro. 
duced in Chinese hamster ovary eetts. In this study we compared 
the thmmbotytic e&t of KZP and rt-PA in doss with etcctrieatty 
induced coranary artery thromboris. Bath agenb were given 
kttmvennusly in equimolar amounti over 20 min after Ihe occlu. 
sive thrombus was stable for 30 min: dogs were monitored for 1 h 
after reperfusion if Row occurred. 
Coronary blond Row was r&wed by rt-PA in 6 (MI%) of 10 
d-s. The restored ROW la&d for 49 + t2 mb, and mean “ow a, 
60 mio from the start of reprfuainn was 7 t 3 mlimin. The 
reocclusion rate was 50% (lhree of six dogs). Flow was restored in 
five 1100%) of five dogs by K2P. The restored blood Row la&d 
during tke entire t.h observation pried in a8 but one dog and 
mean Row at 60 mtn was 49 d 16 mllmin (p < 0.02 vs. Row in 
It-PA-treated d”Ed. 
Remrod coro”Pry hlmd Row showed marked cyrtir ow 
variabons in r&PA-treated but not in KZP-treated dogs. In 
addition, reperfusion ventricular arrhythmias, which were often 
seen in rt-PA-lrsated dogs and required adndnistration of 126 i: 
31 mg 01 lidocaine pa dog, were rarely SIW in dcgs treated wilh 
K2P and no dog in this group neded lidwaine. Bath ptasminogen 
activator antigen levels and tibrtnotytic actiuity in plasma were 
sustained in the KZFtreated dog, whereas l& iariabks re. 
turned to haxline values within 20 to 30 nin after discontinuation 
of R.PA infusion, demonstrating the short half~life of rt.PA in 
plasma. 
Thus, KZP csuses pmlonged thrambalyris devoid of cyclic Bow 
variations and reperfwion arrhytbmips in ibis canine model of 
coronary thromb~ob, and may be superior te rt.PA a~ a thram. 
balytic agent. 
(J Am Co// Ctwdioll992;20:22&35~ 
Human recombinant issue-twc plasminoeen activxor (IT- 
PA) has high Rhrinolytic act&& il.?), an; its use in acute 
myocardial infarction is extensive: it is relatively fibrin 
specific and it has a short half-life that may be a factor in the 
coronary artery reocclusion frequently seen after initial 
thrombolysir witb n-PA (2). The short half-life of rt-PA is 
mainly due to its rapid uptake by the liver and subsequent 
degradation (3). Recently, we showed that vawdilator 
agents such as ilopmst (4) and nitroglycerin (5) may decrease 
the efficacy of r&PA because they enhance hepatic blood 
dew (6.7) and facilitate catabolism of n-PA. Some studies 
(8.9) suggest hat deletion of amino acid residues 6 to 173 
(comprising the fihronectin fingerlike, epidermai growth fac- 
torlike and first kringle domains) and changing A# to Gin 
in the rt-PA molecule can produce a pmtein that has a 
thrombolytic efficacy and fibrin specificity similar to those of 
rt-PA. but a much longer half-life. ‘This protein, called KZP, 
was produced with recombinant echnology in Chinese ham- 
ster ovary cells and purified by immunoaffinity chromatog- 
raphy (8.9). In this study. we compared the titrombolytic 
effect of rt-PA and K2P in dogs with electrically induced 
intrdcoronary thrombosis to determine whether K2P in 
equimolar concentrations is superior to S-PA in inducing 
thrombolysis in dogs with in situ coronary anery thrombus. 
Methods 
Coronary artery thrombosis. Fifteen mongrel dogs of 
either gender weighing 21 kg (range 16 to 22) were anesthe- 
tired with pentobaibnai sodium (30 mglkg body we@w. 
inlubmed and placed on positive pressure ventdatno with a 
Harvard respirator. A left thoracotomy was performed m the 
fifth intercostal space and the heart wnc suspended in a 
per&dial cradle. The left anterior descendinc: corooxy 
artery was isolated distal to the first dtagonal branch. A n&i 
ultrasonic Doppler Row probe (Chrystal Blotechl with an 
inner diameter ranging from 2 to 3.5 mm was placed on the 
artery for monitoring coronary blood Row The probe was 
carefully matched ro the diameter of the nnery in each care 
and was chosen so that it slightly conatiictrd ii,: drlc,? Th; 
Doppler Row meter and the probe were calibrated by mat& 
ing the outpot signal to the sigaal of a cabbrated clechomag- 
netic flow meter (model BL 613, Biarmnexl. lntncoronary 
thrombus was induced by using the techmque iniually de- 
scribed by Romson et al. (IO) and subxquently used by us 
(4.5, and others (II,. In brief. the left anterior descending 
artery was gently rubbed to disrupt the endothelium distal to 
the Row probe and a silver-coated copper wire with a 
Xgaqe needle tip (appioxim8tsly 4 mm1 bsnt W ‘vx 
inserted distal to the Row probe into the artery and pulled 
back to ensure its contact with the intimal surface of the 
vessel. This electrode was connected in series with a 
250,WJiW variable resistor to the anode lposdive termttmll 
of a Y-V nickel-cadmium battery. The cathode (negative 
terminal) was secured to subcutaneous tissue. In all animals. 
an external plastic wcluder was placed on the left anterior 
descending artery distal to the flow probe and elecwxJc to 
reduce peak reactive hyperemia after a IO-s period of total 
occlusion bv ~50%. The thrombus formation was initiated 
with pass& of direct current (100 4) through the intra- 
coronary electrode until coronary blood flow was zero for 
~30 mitt with the electric current turned off and the plastic 
Admi+,trz:mn &ST-PA snd KZF. After the in situ intra- 
curunary thrambus was fully occlusive. as indtcated by zero 
blood Row with the elecrric cur:cot on. the external pli~311c 
occluder was gradually removed and the current abruptly 
turned off. The antmals were then given intravenous normal 
saline solution for 30 min. and the stability of thrombus was 
confirmed. !n this model. there is no spontaneous dissolution 
of the clot after the thrombus has been stable. After a 3C-min 
period of observation. animals were randomly given I m&/kg 
of n-PA (n i 10) or 0.65 mg/kg of KZP In = 5) by the 
inlrrvenou\ route owr B 20.min period. If repelfusion w- 
curred after adminlsrmtion of R-PA or KZP. the dog was 
observed for I h for evtdence ofcoronary anery reocclusion. 
Lidocame was administered as necessary fo control venlric- 
ulnr arrhythmms during reperfusion. The doses of n-PA and 
UP wsre chosen an an eouimolar basis ttbc molecular 
weight of K?P is approxim&ly 65% of that of rl-PA). 
Platelet aggregation shdii. To determine the direct ef- 
fect of n-PA and K2P on canine platelet aggregation, periph- 
eral venous blood was collected in 3.8% sodium cirra!e (911 
volume/volume) from three dogs in the awake state on the 
day before the experiment. Platelet aggregation in whole 
blood was determined by impedance aggregomctry with a 
whole blood platelet aggregometer (model 540 Chronolog) 
(4.5). Blood was incubated with n-PA. K2P OF saline EOIU- 
lion for 5 to IO min before induction of aggregation. The 
siimulus used for whole blood platelet aggregation was 
collagm !2Lnl &nli). 
Scanning electron mie-py. Left anterior descending 
and circumflex coronary aneq segments were dissected 
from the heart at the end of each experiment. The left 
anterior descending coronarv artery was cut into two I-cm 
long segments: the-first at the site of the thrombus and the 
second about 1 cm distal to the thrombus. Tne left circum- 
Rex artery served as a control segment. The arterial seg- 
ments were fixed in I% glutaraldehyde and placed in 1% 
osmium tetroxide in I% cacodylate buffer (pH 7.2). After 
sevwa! wathes in cacodylate buffer, the arteries were deby- 
drated in graded alcohol and I% acetone and refrigerated 
wcmight in amyl acetate. SQecinens were dried to the 
critical point and coated with silver in a Hummer 5 sputter 
coating system (Anatech Ltd.). 
occluder removed. 
In the core of the myocardium supplied by the left 
anterior descending artery. myacardial cegmental shortening 
was measured by placement of ultrasonic crystals in the 
mid-mvocardium. The orientation of the crystals. separated 
by I to I.5 cm. lay transverse to the bzgventrieular axisand 
was aligned so that the optimal acousttc signal was obtained 
(12). Enddiastolic segment length (EDL) and end-systolic 
segment length (ESL) were measured at aortic valve opening 
and closing. respectively, as determined from the aortic root 
pressure waveform (13). Regional myocardial segmental 
function was determined as [(EDL-ESLVEDLI x LOO. A 
catheter was inserted into both femoral veins. advanced into 
the inferior vena cava and used for both drug infusion and 
collection of bkxd samples. 
~emodynamic measuremen(s. In addition to continuous 
measurement of coronary blood Raw. ascending aortic pres- 
sure was measured by inserting a catheter-tip pressure 
transducer (Millar) into a carotid artery and advancing it to 
the amtic root. Heart rate ,was calculated fmm lead II of the 
electrocardiogram. The recordings were made on a Hooey- 
well multichannel recorder. 
Under a dissecting microscope, tissues were cut with a 
razor blade for full exposure of the lumen surface. All 
specimens were examined with a Hitachi S450 scanning 
electron microscope. 
Plnrminogen activator (PA) antiieen level and plasmin~gen 
activator inhibitor-1 (PAM) activity in plasma. Samples of 
titrated penpheml venous blood were collected in sterile 
disposable plastic syringes (Becton-Dickinsmt), transferred 
into p~lypr~pyleo~ tubes and immediately placed on ice. 
Blood samples were collected before thrombus formation 
(control sample), after thrombus formation and at the end of 
drug infusmn. In case thrombolysis occurred, blood samples 
were also collected at the onset of reperfusion, eve.3 5 min 
for the next 20 mio and I h after reperfusion. Blood samples 
were centrifuged at 1,500 g for I5 min and plasma samples 
were stored at -70°C for measurement of PA antigen. which 
war completed within 4 weeks of blood collection. 
Plasminogcn activator antigen and PAI-I levels were 
measured by enzyme-linked immunosorbent assay (ELISA) 
as described oreviouslv (4.5). K2P and r&PA showed eouiv- 
alenl sensiliv& in thebolyclonal ELlSA used in this &dy 
Plasminogen activator activity was also measured by modi- 
fication of the method of Walker et al. (14). Briefly, 6 ml of 
0.1% bovine fibrinogen dissolved in fibrin plate buffa, pH 
7.75, and with a final ionic strength of 0. IS. was pqetted into 
flat-bottomed plastic petri dishes (87.mm diameter) and 4 IU 
of thrombin was added to it. After mix&. the elates were 
left at room temperature for 2 h. Four-25.&I ‘samples of 
plasma collected at different times were assayed on each 
plate. After 18 h of incubation at 37’C, Ihe circular areas of 
fibrinolysis were then measured in mm’ as an index of 
fibrinolytic activity. 
&nts. KZP war obtained from Kabitirn and supptied in 
vials containing IO mg of K2P in IO ml of buffer (0.2 Y 
Are-HCI, 5ll mM PB, pH 7.4). Subsequent dilutions were 
made just before its use. The rt-PA was produced with 
recombinant echnology by Genenrech and was ru?plied io 
50.mg vials. 
Stotielicsl analysis. Data were analyzed with regard to the 
maximal coronal-y artery bleed Row and its dxrntion a!ter 
reperfusion. Time to thrombus formation. time to infusion of 
thiomboly!ic agent and time to rcstomtion of blood flow 
were also determined. Frequeocy of thrombolysis and r:uc- 
clusioo :ates in the two groups of dog< wer: compared using 
the Fisher exact test. E&r of thrombosis and thrombolvtic 
regimen on mycczr?ial function, heart rate, arterial press& 
and ptosma PA antigen and PAI-I levels were compared by 
the Student r test. All data art expressed as mean value t 
SEM. 
Comparalive thrombolytic otferts of &PA and KZP (Table 
1). Left anterior descending anery blood flow before throro- 
bus formation was similar in the two groups of dogs (33 2 
4 mllmin for the n-PA group vs 42 t 4 ml!min for the KZP 
group; p = NS). Mean time to thrombw formation and to 
infusion of the thrombolytic agents was also similar in the 
two uoups. In 6 160%) of the IO dogs, II-PA caused 
reperfusion; mean time to reflow was 23 f 7 min. The 
restored flow was maintained for a 60.min oeriod of obser- 
vation in only three (50%) of six dogs ‘with successful 
thrombolyiis. Mean peak restored flow in the six dogs with 
reperfusion was 57 + I I mllmin; at M) min of reperfusion, the 
magnitude of coronary blood flow was 7 ? 3 mlimin. 
KZP mused wperfusion in all animals. Time to reflow 
was 20 -’ 3 min and mean peak restored flow was 74 + 
9 mllmin (both D = NS vs. r&PA). At 60 mitt of reoerfwion. 
the magnitude bf reslored coronary blood flow ias 49 ? 
16 mllmin (p < 0.02 vs. rt-PA) in these dogs. 
A representative xample of coronary artery occlusion 
induced by electric current. restoration of coronary blood 
flow with rt-PA administration and subsequent spontaneous 
reocclusion is shown in Figure I. During reperfusion with 
Figure L. Representative xperimenr showing induc- 
tion of occIusi#e intracoronary thrombus by delivery 
of analal direct current. Administmtion of human 
reeombinnn! tissue-typr plasminogen a&&x @t-PA) 
causes nonsustained thrombotyris and restomtio” “f 
coronary blood Row. Note the presence ofcyclic Row 
valiaiio”~. AP = aneria, blood o:ess”re: CBF = 
rl-PA, cyclic variations in coronary blood flow tndicating 
platelet activation (4.5) were present until rcocclustott. In 
contrast, KZP administration resulted in significantly pro- 
longed reperfusion (Fig. 2) with fewer cyclic Row wnations. 
suggesting more stable thmmbolysis. 
In addition, ventricular anhythmkx. which were fre- 
quently observed during thrombolysis with R-PA. were 
absent or occurred rarely during KZP-induced thrombolysis. 
The frequency of arrhythmias was not quantitated; however, 
lidocaine was required in all CPA-treated dogs to control 
arrhythmias (mean dose of lidocaine 126 + 31 :~g per dog). 
In the K2P-treated ogs, no lidocaine WBF needed (p < O.WI 
vs. the r&PA group). 
Effects on myoeardial function and syslemic hemudynamics 
(Table 2). Complete occlusion of the left anterior descend- 
ing coronary artery in all dogs resulted in a change in 
end-diastolic and end-systolic segment length. Myocatdial 
sezmcnt dvsfunction indicated by paradoxic left ventricular 
co&ction occurred in II of the-15 dogs. Neither throm- 
bolvtic axent had any effect an segment Function and despite 
the~ittdu&tt of thr&ttbolysis failed to restore normal func- 
tion. The r&PA had only a modest effect on systemic 
hemodynamics; both heart rate and arterial pressure were 
unchanged after repelfusion. In comparison, K2P caused a 
modest but +wican! decrease in mean arterial pressure 
(p < 0.01 vs. rt-PA), without any effect on heart rate. 
EBects of K2P and rt-PA on platelet a~regatioo. Both 
K2P and n-PA had a simiiar concentntion-dependenr inbib 
i!,x:l C?“,C! “C C1”/“C p!zte!e! 1~eg2L... .._ ~. .=. ;,,n ;n l,i,,” IF;” 1, 
Plasma PAL1 and PA antigen levels amI PA activity. The 
PAI-I lerels decreased as the PA antigen levels increased. 
indicating consumption of PAI-I in bath groups ofdogs (Fig. 
4). Howver. in the n-PA group. PAI-I levels began to 
increase at IO mitt after rererfusion and were not di5ercnt 
from baseline values at 35 min. In contrast, PA&I levels 
were mxkedlv and consistently su~orcsscd in the K2P- 
treated dogs throughmt the period of observation. 
The plasma PA antigen levels in both groups of dogs are 
shown to Figure 4. Plasma levels of PA antigen increased 
raoidlv over the oeriod of observation in both groups but 
de&ted to the control (prethrombus) value at M) min in the 
rl-PA group but remained very high in the K2P group. The 
plasma half-life was calculated from rhe antigen elimination 
curve after fitting the terminal data points (IO to 64 min) into 
a straieht line. The half-life for the beta-elimination was I3 2 
5 min after n-PA and was 49 + 1 mitt after K?P administm- 
tibn (p < 0.01). The PA antigen levels in the two groups of 
Table 3. Systemic and Myocardial Effects of Human Recombinant Tissue-Type Plaaminogeen 
Activator (rt-PA) and K?P in Dogs With Reperfurion 
CPA I” = 61 UP ,n = I, 
dogs were different at all times after infusion of the throm- 
bol;tic agent ip < 0.01). 
Sustained plasma PA activtry in the KZP-treated ogs was 
also ewdent from the fibrin lysis assay. For example, after 
60 min of administration, the area of fibrinolysis on iibrin 
plate was 98 I k 104 mm2 in KZP-treated dogs compared with 
II r 7 mm’ in n-PA-treated dogs (p < 0.01). In a repre- 
sentative example (Fig. 5). plasma samples taken from an 
n-PA-treated dog at the onset of reperfusion and at the 
end of n-PA Infusion and Ihe subsequent three samples 
(taken at 5, IO and IS mm after the end of rt-PA infusion) 
caused marked fibrin lysis. but subsequent plasma samples 
showed very little or no tibrinolytic activity, indicating the 
short half-life of n-PA in plasma. In contrast. in a K2P- 
treated dog all plasma samples mcluding the one collected at 
2 h after cessation of K2P revealed potent fibrinolytic 
activity. 
Eleetron microscopic studier. After thrombolysis with rt- 
PA, the reperfused coronary artery revealed deposition of 
fibrin and platelets on its intimal surface. The morphology of 
the coronary artery in a dog treated with K2P is shown in 
Figure 6: the lysed coronary rhrombus with part of the 
thromhus still adherent to the vessel wall is clearly wible. 
Higher power magnification showed the presence of fibrin 
and platelets on the intimal surface. This pattern was not 
sienificantlv different from that seen in the n-PA-treated 
Figw 5. Fibrinolytic activity in plasma samples from dogs given 
human recombinant tissue-type plasminogen activator M-PA) (tap) 
or K2P Ibottom). Plasma samples 3 through 6. taken dutinp. the early 
phases of n-PA therapy, show marked fibrinolylie activity bared on 
Rbrin pla,t asray. However. T”bseq”ent ramp\es 0 thro”%h (2) 
show very little Sbrinolytic activity, suggesting a short half-life of 
n-PA. In con,mt. all sampies 13 through I?_: fmm KZP-treated dew 
show perrirtent Sbrinolytic aetwity. 
Discussion 
This study rhows that the novel rt-PA mutant KZP, as 
compared with CPA, cause3 sustained thrombolysis in dogs 
with occlusive coronary artery thrombus. The coronary 
blood :low Muted by KZP shows only a few cyclic flow 
variations and no reperfusion arrhythmias. 
The coronary thrombosis model. Before discussing these 
results, it is pertinent to discuss the model of coronary 
thrombosis in dogs used in these studies. This model of 
coronary thrombosis has been utilized by several investiga- 
tors to study the &icacy of agents !hl prevent or delay 
intravascular thrombosis (I I), induce thrombolysir (4) or 
prevent coronary artery reocclusion (15). The thrombus 
formed in the coronary artery on delivery of anadal current 
is platelet-dependent because platelet inhibitors delay for- 
mation of the occlusive thrombus (11). The thrombus is 
Figure 6. Scanning elecmn mmscopic mdy of a coronary anery 
subjected 10 thrombosis and thmmbolgsis with KZP. Note the 
residual thrombus and presence of fibrin and platelets on the iaimal 
surface. 
Figure% Scanning electron microscopic study o’a coronary artery 
subjected to thrombosis and thrombalysis with human recombinant 
tissue-type plssminogen xlivalor. Note the pres :nce of fibrin and 
$a!&~ on the lumen surface. The extent of ~latek~ or fibnn 
deposition appears to be similar to thal in the K. P-mated dog in 
Figure 6. 
platelet-rich with incorporation of red blood cells and fibrin. 
and lhe intimal surface of the coronary artery often reveals 
extensive endothelial disruption. These featl,rcs. along with 
external narrowing of the conmary artery designed to mimic 
atherosclerotic narrowing, make this thrombus similar to 
that seen in humans with acute myocardial ischemia (16). 
Coronary artery reocelusion atier rt-PA Lrombolysis. 
When given intravenously in this canine model of coronary 
artery thrombosis, rt-PA predictably induces thrombolysis 
in 50% to 80% ofanimals and the frequency of thmmbolysis 
depends on the amount of n-PA administered. This dose- 
dependent thrombolytic effect of rt-PA is also evident in 
humans with acute myocardial infarction (17). However, the 
coronary artery often reoccludes in both dogs and hnmans 
soon after the infusion of R-PA is discontinued (17-20). This 
rapid rcocclusion appears to be related to the short half-life 
of II-PA in plasma. It also seems to be at least in part a 
platelet-dependent phenomenon because plrrtelet inhibitors 
decrease the frequency of reucciusion (15.21). Fibrin depo- 
sition in the rep&used coronary artery IS also a prominent 
feature and administration of thmmvjn inhibitors such as 
heparin, hirudin and argatroban reduces the frequency of 
coronary artery reocclusion (15.20.22). Although administta- 
tion of aspirin with or without heparin may improve the 
thrnmbolytic efficacy of SPA in the canine model. we and 
others have typically omitted such adjunctive therapy when 
evaluating the efficacy of a new thmmbolytic agent. 
Comparative &eacy of K2P and rt-PA. Because the 
activily of the fibrinolytic agenl may determine the frcre- 
quency of coronary flow restoration and the half-Me of the 
agent may be critical in determining duration of reHow. we 
compared the efficacy of K2P with that of rt-PA in a canine 
holytic a:w~ty aiu n&t specihclty of Ihe’rt-PA mutanr 
KZP. which lack5 the fmgerli4e. epidermal growth factorlikc 
and first kringle domain. are comparable to those of MA in 
a rabbi1 jugular win thrombosis model (8). The deorynho- 
nucleic acid [DNA) construction, protein s~ruc~urc. fibrin 
atTmity and enzymadc properties of KZP have been recently 
described I81 The plaaminagen acrivabx activity of KZP is 
approximately 23% of that of the r&PA molecule in an 
indirect chromogenic assay, but the specific actwlfy detcr- 
xfiilriG w;iik Ft_u 61 yh! as&l; :huns l!::<e !*A Ler !lE!2s 
htghcr q@ir :!g~wiry of K2P than that of n-PA. These 
observalions are clmllar IP the PA acrivity in cancnc p!asma 
delrrmined from fibrin plate assay in this study (Fig. 6). Wu 
e! a!. (9) measured plesma clenrancc of r&PA and K2P in 
does with coooer coil-induced thrombosis and found the 
clear..nce of n-PA 10 be much faster (320 to 510 mlimin) than 
that of KY (27 UJ 39 mllmin). The plasma clearance of K2P 
was no1 atfccted by its dose. Meawrement of PA antigen in 
our srudy also showed sustained plasma levels in KZP- 
treated dogs. 
K2P induced thrombolysis in all dogs, whereas rt-PA 
induced thrombolysis in only 60% of dogs. The reperfused 
coronary artery reoccluded in three (50%) of the six II-PA- 
treated dogs. but in only une (20%) of the five KZP-treated 
dogs. Therefore. mean coronary blood flow was much higher 
in KZP.treated dog over the period of observation. The 
prolonged reperfwk~~ by KZP administration can be cx- 
plained by the high and sustained PA anri8en levels in 
plasma. Indeed. prolonged maintenance infusion of II-PA 
prevents reocclusion (23). !n addition, K2P is asscciated 
with more pmnounced Sinogen degradation than is the 
molar eqwalent dose of rt-PA (9). Because some fibrinogen 
degradation produc!s inbibi: plateler aggregatio!;, it is possi- 
ble that a greater release of fibrinogen degradation products 
contribmsd iu ‘oore pronounced platclct iahib5i:ion and sus- 
tained lhmmholysis in KZP-treated dogs. 
The resrmsion of coronary blood_j%w wifh rl-PA HWS 
associates. wi!h cyclicjloow variarions. The cyclic Row van- 
ations in the narrowed canine coronary artery have been 
auribuijzd to platelet accumulation and are abolished by 
adminixtration of piatelet inhibitors (24). A recent study (25) 
shows that infusion of streptokinase and subsequent plasmin 
generation decrease cyclic Row variation in stenotic coro- 
nary arteries. If KZP (vs. n-PA) causes greater or prolonged 
release of plasmin, this e&t may have contributed to fewer 
cvclic variations in sow after coronary thmmbolysis in the 
K2P group. Even though r&PA decreases pIa:eler aggrega- 
tion in a dose-dependent fashion (26). il was not surprising 
that imracoronary platelet aggregation occurred as the 
plasma PA concentrations declined in n-PA-treated dogs. 
Role of platelet activation in repefused coronary arteries. 
Rep&&n amhythmias have also been thought o be re- 
lated to intracoronary platelet activation and thromboxane 
AZ release (27.28). and fhrir occurrence during !he early 
phase of reprrfusion in rt-PA-treated dogs suggests platelet 
activation in reperfused coronaw arteries. Most KZP-treated 
dogs did not show cyclic flow variations or repetfusion 
arrhythmias: these potentially beneficial phenomena may be 
explained by sustained high levels of PA antigen and fibrin- 
olytic activity. Our in wtro studies suggest lhat the platelet 
aggregation inhibitory activities ofrt-PA and KZP are similar 
and cooncentration dependent. It may be speculated that the 
sustained high levels of PA antigen I” KZP-treated dogs 
reduced myocardial platelet deposition and subsequent re- 
lease of vasoconstrictor suhsrances bv activated p!atelets. 
Role of PA antigen eonceentraiion. The p!asma Ph antigen 
concentrations achieved at the time of repcrfusion after KZP 
administration were higher than those achieved after n-PA 
(Fig. 4). These observations are similar to those of Wu et al. 
(9). It is likely that the higher plasma PA antigen concentra- 
tions achieved in KZP-treated dogs accounted for higher 
rates of thrombolysis and lower Frequency of occlusion of 
the rep&used coronary artery. However, both K2P and 
CPA were used in equimolar concentrations (8). The lower 
plasma PA levels in n-PA-treated dogs are most likely a 
reflection of very rapid clearance of r&PA in the portal 
circulalion. In addition. the apparent short half-life of n-PA 
(13 min) based on multiple determinations of PA antigen in 
plasma over the subsequent 60 min is most likely the basis of 
rapid reocclusion of the coronary artery in dogs with initial 
thrombolysis. In contrast. K2P has a long apparent half-life 
149 mird in doe plasma. These concerts are supmwted bv 
rapid recoverybi PAI-I levels in the rt:PA-treated dogs but 
a prolonged suppression of PAL-I in the KZP.treated dogs 
(Fig. 4). 
data from experimental animals can he cxtra?ntated to the 
clinical reiting. 
Mechanism of persistent proccmgulant activity during 
thrombolysls. The reperiused coronary arteries of dogs 
treated with rt-PA showed extensive platelet and fibrin 
deposition. We bad expected K2P to prevent platelet and 
fibrin deposition in the reprrfused coronary arteries, but 
scanning electrirn microscopy continued 10 show residual 
thrombus. platelet and fibrin deposition. Deposition of plate- 
lets and fibrin may reflect the persistence of procoagulant 
activity during thmmbalysis and may account for the occur- 
rence of rethrombosis (29). Several mechanisms for persist- 
ent procoagulant activity durmg thromholysis ha& been 
identified; these include expression of procoagulant factors 
in association with massive arterial wall injury (30), as well 
as the potent pmcoagulant effect of the residual thrombus 
(31). In addition, alterations in the regulation of fibrinolytic 
and coagulant proprieties of endothelium (32) and activation 
of plasmmoeen with fomxition of ulasmin (33) may lead to 
w&&m oi thrombi”, which indices fibrin formation and 
platelet activation. These obs:rvatiors support the need for 
therapy with antiplatelet drugs and th nmhin inhibitors soon 
after or in conjunction with thmmbolytic therapy, regardless 
of the thromholgtic regimen. 
Conclusions. WC have described the potent hrombolytk 
etfects of K2P. an rt-PA mutant. Trials of this 2nd othe! 
mutants in humans are needed to determine whether these 

